These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


700 related items for PubMed ID: 19681291

  • 1. Main bile duct carcinoma management. Our experience on 38 cases.
    Cavallaro A, Cavallaro V, Di Vita M, Cappellani A.
    Ann Ital Chir; 2009; 80(2):107-11. PubMed ID: 19681291
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome.
    Heron DE, Stein DE, Eschelman DJ, Topham AK, Waterman FM, Rosato EL, Alden M, Anne PR.
    Am J Clin Oncol; 2003 Aug; 26(4):422-8. PubMed ID: 12902899
    [Abstract] [Full Text] [Related]

  • 4. What constitutes long-term survival after surgery for hilar cholangiocarcinoma?
    Klempnauer J, Ridder GJ, Werner M, Weimann A, Pichlmayr R.
    Cancer; 1997 Jan 01; 79(1):26-34. PubMed ID: 8988723
    [Abstract] [Full Text] [Related]

  • 5. [Diagnostics and treatment of cholangiocarcinoma].
    Mantel HT, Verdonk RC, van Dullemen HM, Gietema JA, Slooff MJ, Porte RJ.
    Ned Tijdschr Geneeskd; 2008 May 03; 152(18):1037-41. PubMed ID: 18547024
    [Abstract] [Full Text] [Related]

  • 6. Surgical therapy for hiliar cholangiocarcinoma: analysis of 198 cases.
    Zhang BH, Cheng QB, Luo XJ, Zhang YJ, Jiang XQ, Zhang BH, Yi B, Yu WL, Wu MC.
    Hepatobiliary Pancreat Dis Int; 2006 May 03; 5(2):278-82. PubMed ID: 16698591
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma.
    Hirohashi K, Uenishi T, Kubo S, Yamamoto T, Tanaka H, Shuto T, Yamasaki O, Horii K, Kinoshita H.
    J Hepatobiliary Pancreat Surg; 2002 May 03; 9(2):233-6. PubMed ID: 12140612
    [Abstract] [Full Text] [Related]

  • 9. Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: prognostic factors and longterm outcomes.
    Baton O, Azoulay D, Adam DV, Castaing D.
    J Am Coll Surg; 2007 Feb 03; 204(2):250-60. PubMed ID: 17254929
    [Abstract] [Full Text] [Related]

  • 10. Liver transplantation for hilar cholangiocarcinoma.
    Thelen A, Neuhaus P.
    J Hepatobiliary Pancreat Surg; 2007 Feb 03; 14(5):469-75. PubMed ID: 17909715
    [Abstract] [Full Text] [Related]

  • 11. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
    Zeng ZC, Tang ZY, Fan J, Zhou J, Qin LX, Ye SL, Sun HC, Wang BL, Li D, Wang JH, Zeng MS, Guo W, Tan YS.
    Cancer J; 2006 Feb 03; 12(2):113-22. PubMed ID: 16630402
    [Abstract] [Full Text] [Related]

  • 12. Surgical management of cholangiocarcinoma.
    Jarnagin WR, Shoup M.
    Semin Liver Dis; 2004 May 03; 24(2):189-99. PubMed ID: 15192791
    [Abstract] [Full Text] [Related]

  • 13. Long-term outcomes after hepaticojejunostomy for choledochal cyst: a 10- to 27-year follow-up.
    Ono S, Fumino S, Shimadera S, Iwai N.
    J Pediatr Surg; 2010 Feb 03; 45(2):376-8. PubMed ID: 20152355
    [Abstract] [Full Text] [Related]

  • 14. Our experiences in surgical treatment for hilar cholangiocarcinoma.
    Maeno H, Ono T, Yamanoi A, Nagasue N.
    Hepatogastroenterology; 2007 Feb 03; 54(75):669-73. PubMed ID: 17591038
    [Abstract] [Full Text] [Related]

  • 15. Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients.
    Lang H, Sotiropoulos GC, Sgourakis G, Schmitz KJ, Paul A, Hilgard P, Zöpf T, Trarbach T, Malagó M, Baba HA, Broelsch CE.
    J Am Coll Surg; 2009 Feb 03; 208(2):218-28. PubMed ID: 19228533
    [Abstract] [Full Text] [Related]

  • 16. Extended hepatic resection and outcomes in intrahepatic cholangiocarcinoma.
    Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H, Shimamura F, Shimizu Y, Miyazaki M.
    J Hepatobiliary Pancreat Surg; 2003 Feb 03; 10(4):259-64. PubMed ID: 14598144
    [Abstract] [Full Text] [Related]

  • 17. In-continuity hepatic resection for advanced hilar cholangiocarcinoma.
    Zervos EE, Pearson H, Durkin AJ, Thometz D, Rosemurgy P, Kelley S, Rosemurgy AS.
    Am J Surg; 2004 Nov 03; 188(5):584-8. PubMed ID: 15546575
    [Abstract] [Full Text] [Related]

  • 18. The multidisciplinary management of gastrointestinal cancer. Biliary tract cancers: from pathogenesis to endoscopic treatment.
    Demols A, Maréchal R, Devière J, Van Laethem JL.
    Best Pract Res Clin Gastroenterol; 2007 Nov 03; 21(6):1015-29. PubMed ID: 18070701
    [Abstract] [Full Text] [Related]

  • 19. [Long-term results of 84 surgically treated patients with extrahepatic bile duct carcinoma].
    Zheng SS, Qin YS, Liang TB, Huang DS, Zhang M, Wang WL, Shen Y, Wang JH.
    Zhonghua Zhong Liu Za Zhi; 2005 Sep 03; 27(9):554-6. PubMed ID: 16438856
    [Abstract] [Full Text] [Related]

  • 20. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F, Agni R, Rettammel RJ, Been MJ, Cho CS, Mahvi DM, Rikkers LF, Weber SM.
    Ann Surg; 2008 Aug 03; 248(2):273-9. PubMed ID: 18650638
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 35.